Shopping Cart
Remove All
Your shopping cart is currently empty
ZNL-0056 is an orally active ATP-competitive inhibitor that targets the EGFR ATP-binding site, specifically Cys797 and Cys775. It selectively inhibits EGFR and its downstream signaling in H3255 cells. ZNL-0056 is applicable for cancer research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | ZNL-0056 is an orally active ATP-competitive inhibitor that targets the EGFR ATP-binding site, specifically Cys797 and Cys775. It selectively inhibits EGFR and its downstream signaling in H3255 cells. ZNL-0056 is applicable for cancer research. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.